Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Prostatic Neoplasms 19Lung Neoplasms 15Multiple Myeloma 13Leukemia, Myeloid, Acute 12Glioma 10Wilms Tumor 9Lymphoma, Non-Hodgkin 9Breast Neoplasms 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Osteosarcoma 8Neuroblastoma 8Neoplasm Metastasis 8Myelodysplastic Syndromes 8Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 8Rhabdoid Tumor 7Hepatoblastoma 7Rhabdomyosarcoma 6Ovarian Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 6Medulloblastoma 6Lymphoma 6Histiocytosis, Langerhans-Cell 6Ependymoma 6Sarcoma, Ewing 5Rectal Neoplasms 5Pancreatic Neoplasms 5Leukemia, Myelomonocytic, Chronic 5

Interventions

Doxorubicin 7pembrolizumab 5Specimen Handling 4Radiotherapy 4palbociclib 3eribulin 3Radiation 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Biopsy 3pazopanib 2brigimadlin 2abemaciclib 2Immunoglobulin G 2zimberelimab 1toripalimab 1talimogene laherparepvec 1silmitasertib 1selinexor 1ribociclib 1peposertib 1pemigatinib 1olaratumab 1olaparib 1mirdametinib 1liposomal doxorubicin 1lenvatinib 1enzalutamide 1durvalumab 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma × X-Rays × 1 year × Clear all
NCT06422806 2026-05-26

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

National Cancer Institute (NCI)

Phase 3 Recruiting
365 enrolled
Sarcoma

Liposarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡